5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like The Battle Between Two $1B+ Biotech Unicorns November 5, 2017 GlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head January 18, 2017 Pfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest January 7, 2018